Statistical Methods for Dose-Finding Experiments of Statistics in Practice, 2006. ,
Pharmacokinetic/pharmacodynamic modeling in drug research and development, J. Clin. Pharmacol, vol.40, issue.12, pp.1399-1418 ,
A survey of the way pharmacokinetics are reported in published phase i clinical trials, with an emphasis on oncology, Clin. Pharmacokinet, vol.48, issue.6, pp.387-395, 2009. ,
URL : https://hal.archives-ouvertes.fr/inserm-00409057
Combining multiple comparisons and modeling techniques in dose-response studies, Biometrics, vol.61, issue.3, pp.738-748, 2005. ,
Improved designs for dose escalation studies using pharmacokinetic measurements, Stat. Med, vol.15, issue.15, pp.15-1605, 1996. ,
A novel Bayesian decision procedure for early-phase dose-finding studies, J. Biopharm. Stat, vol.9, issue.4, pp.583-597, 1999. ,
A bayesian approach for dose-escalation in a phase i clinical trial incorporating pharmacodynamic endpoints, J. Biopharm. Stat, vol.17, issue.6, 2007. ,
Dosefinding methods for phase I clinical trials using pharmacokinetics in small populations, Biom. J, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-01560222
R: a language and environment for statistical computing, R Foundation for Statistical Computing, 2013. ,
Easy-to-implement Bayesian methods for dose-escalation studies in healthy volunteers, Biostatistics, vol.2, issue.1, pp.47-61, 2001. ,
Continual reassessment method: a practical design for phase 1 clinical trials in cancer, Biometrics, vol.46, issue.1, pp.33-48, 1990. ,
Influence of the size of cohorts in adaptive design for nonlinear mixed effects models: an evaluation by simulation for a pharmacokinetic and pharmacodynamic model for a biomarker in oncology, Pharm. Res, vol.32, issue.10, pp.3159-3169, 2015. ,
URL : https://hal.archives-ouvertes.fr/inserm-01179444
Cran task view: clinical trial design, monitoring, and analysis, pp.2017-2027, 2016. ,